Vulvar Cancer Global Clinical Trials Review, H2, 2018

GlobalData
102 Pages - GLDATA66240
$2,500.00

Summary

GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Vulvar Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Vulvar Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Companies Mentioned
Merck & Co Inc
Bristol-Myers Squibb Co
GlaxoSmithKline Plc
AstraZeneca Plc
F. Hoffmann-La Roche Ltd
ISA Pharmaceuticals BV
Yangshengtang Co Ltd
Xiamen Innovax Biotech Co Ltd
Inovio Pharmaceuticals Inc
E. Merck KG

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Vulvar Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Vulvar Cancer to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Vulvar Cancer Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 35
Appendix 100
Abbreviations 100
Definitions 100
Research Methodology 101
Secondary Research 101
About GlobalData 101
Contact Us 102
Disclaimer 102
Source 102

List of Tables
Vulvar Cancer Therapeutics, Global, Clinical Trials by Region, 2018* 7
Vulvar Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vulvar Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Vulvar Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Vulvar Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Vulvar Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Vulvar Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 20
Vulvar Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Vulvar Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Vulvar Cancer Therapeutics, Global, Clinical Trials by Phase, 2018* 23
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
Vulvar Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Vulvar Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Vulvar Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34

List of Figures
Vulvar Cancer Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Vulvar Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vulvar Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Vulvar Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Vulvar Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Vulvar Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Vulvar Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 20
Vulvar Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Vulvar Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Vulvar Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
Vulvar Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Vulvar Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Vulvar Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 101

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports